Date | Research Firm | Action | Current | PT |
---|---|---|---|---|
3/31/21 | HC Wainwright & Co. | Maintains | Buy | 55.0 |
12/08/20 | Credit Suisse | Maintains | Outperform | 68.0 |
12/08/20 | SVB Leerink | Maintains | Outperform | 65.0 |
11/19/20 | Cantor Fitzgerald | Initiates Coverage On | Overweight | 61.0 |
9/08/20 | HC Wainwright & Co. | Initiates Coverage On | Buy | 53.0 |
7/14/20 | SVB Leerink | Initiates Coverage On | Outperform | 54.0 |
7/14/20 | Jefferies | Initiates Coverage On | Buy | 54.0 |
7/14/20 | Credit Suisse | Initiates Coverage On | Outperform | 64.0 |
Forma Therapeutics Hldgs analyst ratings
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.